NCT01468389 Taxanes or Platinum in Combination With Capecitabine Followed by Capecitabine Alone as First Line Treatment for Patients With Advanced Adenocarcinoma of Stomach or Esophagogastric Junction Status UNKNOWN Phase PHASE3
NCT01466569 An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01464918 Safety and Efficacy of Using MASTER to Perform Endoscopic Submucosal Dissection in Human Status UNKNOWN Phase NA
NCT01461057 A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer Status COMPLETED Phase PHASE2
NCT01457846 Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer Status TERMINATED Phase PHASE2
NCT01456598 Efficacy of Laparoscopic Subtotal Gastrectomy With D2 Lymph Node Dissection for Locally Advanced Gastric Cancer Status COMPLETED Phase NA
NCT01450696 A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer Status TERMINATED Phase PHASE3
NCT01444755 The Effect of Neoadjuvant Chemotherapy on Locally Advanced Gastric Cancer Status UNKNOWN Phase N/A
NCT01444521 Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer Status COMPLETED Phase PHASE2
NCT01444456 Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia Status COMPLETED Phase N/A
NCT01441310 Laparoscopic Sentinel Node Navigation Surgery for Gastric Cancer Status COMPLETED Phase PHASE2
NCT01433861 Laparoscopy-assisted Proximal Gastrectomy Versus and Laparoscopy-assisted Total Gastrectomy Status TERMINATED Phase PHASE3
NCT01426646 S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric Cancer Status UNKNOWN Phase PHASE2
NCT01412294 XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric Cancer Status UNKNOWN Phase PHASE2
NCT01411189 Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy Status COMPLETED Phase PHASE3
NCT01411176 Phase III Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy Status COMPLETED Phase PHASE3